Get Started

RVPH

PINK Reviva Pharmaceuticals Holdings, Inc.
Oct 25, 2026 · 2:50 PM ET EOD Market Closed

$0.4480 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4480, $0.0520 below the day’s high of $0.5000

YTD change
-91.97%
vs 20-day SMA
-7.24%
vs 200-day SMA
-73.75%

Price ranges

Previous day
$0.4052 $0.5000
open $0.4052 close $0.4480
+$0.0428 (+10.56%)
Today
$0.4052 $0.5000
$0.4480
Past week
$0.3850 $0.5117
from $0.4750 now $0.4480
-$0.0270 (-5.68%)
Past month
$0.3850 $0.5395
from $0.5200 now $0.4480
-$0.0720 (-13.85%)
This year
$0.1700 $5.5800
from $5.5800 now $0.4480
-$5.1320 (-91.97%)

Price & Performance

-0.44 (-49.29%) / 6M

$0.2884$0.5015$0.7145$0.9276Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.8% away from all-time highs of $192.2000
  • RVPH is down 92% since the beginning of the year
  • RVPH is down 96% over the past 12 months
  • RVPH is down 14% over the past 1 month
  • 3% of all RVPH investors are betting against RVPH

RVPH reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -24.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.19
Earnings momentum +34.5% Quarterly EPS growth
Quarterly change +34.5%

Valuation

P/E ratio N/A
Enterprise value $-13471700.0
Beta 1.46

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$19.9M
Debt$144.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.9M

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.